Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dermatologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Automatic differentiation of melanoma and melanocytic nevi with multispectral digital dermoscopy: a feasibility study.J Am Acad Dermatol. 2001; 44: 207-218
- The performance of MelaFind: a prospective multicenter study.Arch Dermatol. 2011; 147: 188-194
- Negative predictive value of pigmented lesion evaluation by multispectral digital skin lesion analysis in a community practice setting.J Clin Aesthet Dermatol. 2015; 8: 745-747
- Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions.Br J Dermatol. 2002; 146: 448-457
- From colour to tissue histology: physics-based interpretation of images of pigmented skin lesions.Med Image Anal. 2003; 7: 489-502
- The distribution of melanin in skin determined in vivo.Br J Dermatol. 2007; 156: 620-628
- Assessment of nurse-led screening of pigmented lesions using SIAscope.J Plast Reconstr Aesthet Surg. 2007; 60: 639-645
- Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomized controlled trial.BMJ. 2012; 345: e4110
- Impact of guidance from a computer-aided multispectral digital skin lesion analysis device on decision to biopsy lesions clinically suggestive of melanoma.Arch Dermatol. 2012; 148: 541-543
- Impact of guidance from a multispectral digital skin lesion analysis device on dermatology residents' decisions to biopsy lesions clinically suggestive of melanoma.J Am Acad Dermatol. 2013; 68: AB152
- Impact of guidance provided by a multispectral digital skin lesion analysis device following dermoscopy on decisions to biopsy atypical melanocytic lesions.J Clin Aesthet Dermatol. 2015; 8: 21-24
- The impact of multispectral digital skin lesion analysis on German dermatologist decisions to biopsy atypical pigmented lesions with clinical characteristics of melanoma.J Clin Aesthet Dermatol. 2015; 8: 27-29
- Pigmented skin lesion biopsies after computer-aided multispectral digital skin lesion analysis.J Am Osteopath Assoc. 2015; 115: 666-669
- Enhancement of international dermatologists’ pigmented skin lesion biopsy decisions following dermoscopy with subsequent integration of multi-spectral digital skin lesion analysis.J Clin Aesthet Dermatol. 2016; 9: 53-55
Farberg AS, Winkelmann RR, Tucker N, et al. The impact of quantitative data provided by a multi-spectral digital skin lesion analysis device on dermatologists’ decisions to biopsy pigmented lesions. J Clin Aesthet Dermatol, in press.
- The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic.Br J Dermatol. 2007; 156: 1350-1352
- Spectrophotometric intracutaneous analysis versus dermoscopy for the diagnosis of pigmented skin lesions: prospective, double-blind study in a secondary reference centre.Melanoma Res. 2009; 19: 176-179
- Automated melanoma detection with a novel multispectral imaging system: results of a prospective study.Phys Med Biol. 2005; 50: 1675-1687
- Multispectral imaging and artificial neural network: mimicking the management decision of the clinician facing pigmented skin lesions.Phys Med Biol. 2007; 52: 2599-2613
Article info
Publication history
Published online: August 07, 2017
Footnotes
Relevant Conflicts of Interest: Drs R.R. Winkelmann, A.S. Farberg and D.S. Rigel served as a consultant to MelaSciences, Inc. Dr A.M. Glazer has no conflicts.
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
